Cure AHC

Cure AHC is a non-profit research organization dedicated to finding a cure for Alternating Hemiplegia of Childhood (AHC), a rare and devastating neurological disorder. The organization focuses on accelerating the development of therapies targeting mutations in the ATP1A3 gene, which is responsible for the majority of AHC cases. Cure AHC actively funds and manages collaborative research projects involving gene therapy, antisense oligonucleotides, and drug repurposing. By partnering with leading academic institutions and biotechnology companies, the foundation aims to move promising treatments from the laboratory to clinical trials. Additionally, Cure AHC maintains a comprehensive patient registry and provides essential support and advocacy for the global AHC community.